RGX-314 Gene Therapy Pharmacodynamic Study for Neovascular Age-related Macular Degeneration (nAMD)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Wet Age-related Macular Degeneration
Related studies linked through entity extraction aliases.
First in Human Study to Evaluate the Safety and Tolerability of EYP-1901 in Patients With Wet Age Related Macular Degeneration (wAMD)
- Status
- COMPLETED
- Phase
- PHASE1
Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Effectiveness of Anti-VEGF Treatments in Wet AMD in Active Smokers
- Status
- COMPLETED
- Phase
- N/A
Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Safety Study of KHK4951 in Healthy Volunteers and Patients With Wet Age-Related Macular Degeneration
- Status
- TERMINATED
- Phase
- PHASE1
The Study of Drug SCT510A in Patients With Wet Age-related Macular Degeneration (wAMD)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
MMP-9 Inhibition for Recalcitrant Wet AMD
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Comparing SCD411 and Eylea® in Subjects With Wet Age-related Macular Degeneration (AMD)
- Status
- COMPLETED
- Phase
- PHASE3
The Study of Drug 601 in Patients With Wet Age-related Macular Degeneration (wAMD)
- Status
- UNKNOWN
- Phase
- PHASE1
Evaluation of RC28-E Injection in Wet Age-related Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Treat and Extend Analysis Trial With Aflibercept in Wet-AMD
- Status
- UNKNOWN
- Phase
- PHASE3
Assessment of Proactive Treatments in Patients With Wet Age-related Macular Degeneration (wAMD) Which Have Never Undergone Treatment of This Particular Disease
- Status
- COMPLETED
- Phase
- N/A
Exploratory Study to Investigate the Bioactivity, Ocular and Systemic Safety, Tolerability, and Pharmacokinetics Following Single and Multiple Intravitreal Administrations of KSI-301 in Subjects With wAMD, DME and RVO
- Status
- TERMINATED
- Phase
- PHASE1
ADVM-022 Intravitreal Gene Therapy for Wet AMD
- Status
- COMPLETED
- Phase
- PHASE1
AAVCAGsCD59 for the Treatment of Wet AMD
- Status
- COMPLETED
- Phase
- PHASE1
Evaluate the Therapeutic Effects and Safety of ALK4290 in Patients With Refractory Wet Age-Related Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE2
Evaluate the Effects and Safety of ALK4290 in Patients With Newly Diagnosed Wet Age-Related Macular Degeneration
- Status
- COMPLETED
- Phase
- PHASE2
Ziv-aflibercept Efficacy in Better Regulating AMD
- Status
- COMPLETED
- Phase
- PHASE2
Observational Study to Assess Intravitreal Aflibercept Injections Used in a "Treat and Extend" Regimen in Treatment-naïve Wet Age-related Macular Degeneration Patients
- Status
- COMPLETED
- Phase
- N/A